Previous 10 | Next 10 |
Search all stock news releases related news releases and press releases from US and Canada Markets.
2024-04-01 08:00:07 ET Gus Richard from Northland Securities issued a price target of $36.50 for SMTC on 2024-04-01 06:47:00. The adjusted price target was set to $36.50. At the time of the announcement, SMTC was trading at $27.49. The overall price target consensus is a...
2024-04-01 08:00:06 ET Harsh Kumar from Piper Sandler issued a price target of $40.00 for SMTC on 2024-04-01 06:45:00. The adjusted price target was set to $40.00. At the time of the announcement, SMTC was trading at $27.49. The overall price target consensus is at $36.5...
2024-04-01 08:00:06 ET Tristan Gerra from Robert W. Baird issued a price target of $50.00 for SMTC on 2024-04-01 06:46:00. The adjusted price target was set to $50.00. At the time of the announcement, SMTC was trading at $27.49. The overall price target consensus is at $...
Addressing the growing need for complete ICP-MS and ICP-OES workflow automation in the lab Agilent Technologies Inc. (NYSE: A) today announced the launch of the Advanced Dilution System , the ADS 2, a new automation workflow solution that will increase productivity, lower cost of owne...
SAN DIEGO, April 01, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc . (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery, today announced that it has entered into definitive agreements for the purchase and sale of 5,454,548 shares of the Company’s common sto...
PALM BEACH GARDENS, Fla., April 01, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental market, today announced that it has closed the previously communicated sale of its Spine business to an affiliate of H.I.G. Capital for $375 million in total consid...
NEW YORK, April 01, 2024 (GLOBE NEWSWIRE) -- AdTheorent Holding Company, Inc. (“AdTheorent” or the “Company”) (Nasdaq: ADTH), a machine learning pioneer delivering measurable value for programmatic advertisers, and Cadent, LLC (“Cadent”), a leading provid...
$17.8 Million Raised Since Beginning of 2023 $9.1 Million of Debt Converted to Equity at a Premium Phase 3 ADHD Data Continues to Impress KANSAS CITY, Kan., April 01, 2024 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Pr...
$17.8 Million Raised Since Beginning of 2023 $9.1 Million of Debt Converted to Equity at a Premium Phase 3 ADHD Data Continues to Impress KANSAS CITY, Kan., April 01, 2024 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Pr...
On Monday, March 25, 2024, Company filed FTZ application and expects final determination within 30 to 90 days FTZ status and benefits would include opportunity for improving Company cash flow through reduction of taxes, fees and deferment of import duties Mullen estimates ...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
12.2%Change Percent:
Penumbra Inc. Company Name:
PEN Stock Symbol:
NYSE Market:
penumbrainc.com Website: